Clinical trial · Interventional
Effect of Myoma Removal on Blood Pressure and Erythropoetin Level
NCT00898170CI-TRIAL-00002296completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The effect of myoma removal was studied on 28 patients with hypertension and myoma by holter monitoring and erythropoetin level check.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hypertension | — | UNRESOLVED | — |
| Myoma | Myoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| myoma removal | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- myoma, with or without hypertension
- description
- those with myoma with or without hypertension in holter monitoring
- interventionNames
- Procedure: myoma removal
Primary outcomes (1)
- measure
- 24 hour holter monitoring of blood pressure
- timeFrame
- 6 weeks
Secondary outcomes (1)
- measure
- erythropoetin level
- timeFrame
- 6 weeks
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 22 Years
- Maximum age
- 55 Years
Show eligibility criteria text
Inclusion Criteria: * candidate for myoma removal by hysterectomy * operable * hysterectomy is indicated Exclusion Criteria: * patient refusal * inoperable patients * other secondary cases of hypertension
References
Publications (0)
Data not yet available
No reference posted for this study.